2,324
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Prevalence of and risk factors for chronic kidney disease in ten metropolitan areas of China: a cross-sectional study using three kidney damage markers

, , , , , , , , & show all
Article: 2170243 | Received 28 Sep 2022, Accepted 13 Jan 2023, Published online: 31 Jan 2023

References

  • Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
  • GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020; Feb 29395(10225):709–733.
  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822.
  • Chinese Center for Disease Control and Prevention. Report on chronic disease risk factor surveillance in China. 1 ed. Beijing: People’s Medical Publishing House Co., LTD; 2021.
  • Lin Z, Qing-Qing C, Ding-Yang L, et al. Meta-analysis of the prevalence and risk factors of chronic kidney disease. Chinese J Gerontol. 2018;38(9):2135–2138.
  • Shan-Zhi W, Yong-Jun Z, Wen-Zhuang T, et al. Meta-analysis of the prevalence of chronic kidney disease in Chinese adults and the elderly. Chinese J Gerontol. 2017;37(21):5384–5388.
  • Yang-Yang K, Zhang-Suo L, Dong-Wei L. Prevalence of adult chronic kidney disease in China: a meta-analysis. Chinese J Pract Int Med. 2016;36(9):785–789.
  • Neild GH. Primary renal disease in young adults with renal failure. Nephrol Dial Transplant. 2010;25(4):1025–1032.
  • Neild GH. What do we know about chronic renal failure in young adults? Primary renal disease. Pediatr Nephrol. 2009;24(10):1913–1919.
  • Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258–264.
  • Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390(10112):2549–2558.
  • Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association: national cross-sectional study. Bmj. 2020;369:m997.
  • National Bureau of Statistics [Internet]. Statistical bulletin of national economic and social development of the People's Republic of China in 2021 [accessed 2022 Feb 28]. Available from: http://www.stats.gov.cn/tjsj/zxfb/202202/t20220227_1827960.html
  • Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. May 5
  • Kong X, Ma Y, Chen J, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant. 2013;28(3):641–651.
  • Xie P, Huang JM, Lin HY, et al. CDK-EPI equation may be the most proper formula based on creatinine in determining glomerular filtration rate in Chinese patients with chronic kidney disease. Int Urol Nephrol. 2013;45(4):1057–1064.
  • Expert Group on Kidney Clinical Quality Control Center in Shanghai. Guidelines for early screening, diagnosis, prevention and treatment of chronic kidney disease (2022 edition). Chin J Nephrol. 2022;(05):453–464.
  • Leão LRS, Mussi TC, Yamauchi FI, et al. Common pitfalls in renal mass evaluation: a practical guide. Radiol Bras. 2019;52(4):254–261.
  • Robins SA, Fischmann J. Hydronephrosis; a radiologic classification based on anatomical variations. Radiology. 1948 May;50(5):632–638.
  • Rodriguez MM. Congenital Anomalies of the kidney and the urinary tract (CAKUT). Fetal Pediatr Pathol. 2014;33(5-6):293–320.
  • Ultrasound Physician Branch of Chinese Medical Doctor Association. Chinese guidelines for abdominal ultrasound examination. 1st ed. Beijing: People’s Medical Publishing House; 2021.
  • Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2017;71(6):e13–e115.
  • Endocrinology Branch of Chinese Medical Association. Multidisciplinary clinical consensus on diagnosis and treatment of obesity (2021 edition). Chinese J Endocrinol Metab. 2021;37(11):959–972.
  • American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021; 44(Suppl 1):S15–s33.
  • Task Force Members,ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205.
  • Nagata M, Ninomiya T, Doi Y, et al. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama study. Nephrol Dial Transplant. 2010;25(8):2557–2564.
  • Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–481.
  • Lu-Xia Z, Hai-Yan W. Current status of chronic kidney disease in China and the challenge to laboratory medicine. Chinese J Lab Med. 2012;35(9):769–772.
  • Fujii Y, Ajima J, Oka K, et al. Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol. 1995;27(2):124–127.
  • Zhang B, Wang H, Sun N, et al. Incidence, diagnosis and treatment of children’s congenital abnormalities of the kidney and urinary tract detected in ultrasound screening. Zhonghua Er Ke Za Zhi. 2011;49(7):534–538.
  • Bikbov B, Perico N, Remuzzi G. Disparities in chronic kidney disease prevalence among males and females in 195 countries: analysis of the global burden of disease 2016 study. Nephron. 2018;139(4):313–318.
  • Carrero JJ, Hecking M, Chesnaye NC, et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–164.
  • Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin c-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749.